A Study of ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

NCT05370755 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Advanced Solid Tumors

Interventions

DRUG: ICP-189

Sponsor

Beijing InnoCare Pharma Tech Co., Ltd.